Mustafa SS, Shroba J. Transitioning peanut-allergic individuals from FDA-approved peanut oral immunotherapy (POIT) to a dietary peanut product. Ann Allergy Asthma Immunol 2022 Oct 6. pii: S1081-1206(22)01822.
PMID: 36210007